Lv4
540 积分 2024-01-22 加入
Evaluating the Impact of AI-Based Model-Informed Drug Development (MIDD): A Comparative Review
7小时前
待确认
Model-informed precision dosing in inflammatory bowel diseases
3个月前
已完结
Prediction of In Vivo Clearance and Associated Variability of CYP2C19 Substrates by Genotypes in Populations Utilizing a Pharmacogenetics-Based Mechanistic Model
8个月前
已完结
Escitalopram population pharmacokinetics and remedial strategies based on CYP2C19 phenotype
8个月前
已完结
Predicting Escitalopram Exposure to Breastfeeding Infants: Integrating Analytical and In Silico Techniques
8个月前
已完结
Assessing pharmacokinetic differences in Caucasian and East Asian (Japanese, Chinese and Korean) populations driven by CYP2C19 polymorphism using physiologically-based pharmacokinetic modelling
9个月前
已完结
Population pharmacokinetic/pharmacodynamic modeling of delayed effect of escitalopram-induced QT prolongation
9个月前
已完结
Machine Learning‐Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents
9个月前
已完结
Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France
1年前
已关闭
Pharmacoeconomics of Bronchial Asthma
1年前
已完结
皖公网安备34019202002308
